[Malvern, PA, October 18, 2023] — LifeSensors Inc., a biotech company targeting the ubiquitin proteasome system for drug discovery and diagnostic markers, has received funding from the National Institute on Aging and National Institute of General Medicine. The funding, to the tune of $5.53 million, provides for the development of PROTAC drug discovery technologies. PROTACs […]
MALVERN, Pa., SEP 21, 2023 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, molecular glue drug discovery and neurodegeneration diagnostics has been invited to speak at the 21st annual Discovery on Target 2023. Dr. Karteek Kadimisetty, LifeSensors’ Director of Research and Development will be presenting new information, and answering questions regarding PROTACs, […]
MALVERN, Pa., SEP 1, 2022 – LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, molecular glues, and neurodegeneration diagnostics, is pleased to announce that Lifesensors has published a seminal paper: Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation. This paper is published in the Biochemical and Biophysical […]
LifeSensors is Attending ASCB | EMBO Cell Bio 2022 MALVERN, PA., AUG 30, 2022 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTACs, molecular glues, and neurodegeneration diagnostics will present new technologies that target ubiquitin E3 ligases and uncover unique molecules. The company will be presenting two posters. One presentation focuses on […]
LifeSensors Invited to Speak at the Industry’s Preeminent 20th Annual Discovery on Target Conference MALVERN, Pa., AUG 30, 2022 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, molecular glue drug discovery and neurodegeneration diagnostics has been invited to speak at Discovery on Target 2022. Dr. Karteek Kadimisetty, LifeSensors’ Director of Research […]
LifeSensors Attending the 5th Annual Targeted Protein Degradation Summit MALVERN, PA., AUG 30, 2022 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, Molecular Glues, and neurodegeneration diagnostics has been invited to speak at 5th Targeted Protein Degradation Summit in Boston MA. Dr. Karteek Kadimisetty, LifeSensors’ Director of Research and Development will be presenting […]
LIFESENSORS TO SPONSOR DISCOVERY ON TARGET To help further scientific advancement in the field of ubiquitin, LifeSensors has partnered with CHI to assist with their Discovery on Target conference this September in Boston. This event will provide unique insight into the state of the field, and how we as scientists can work together to resolve […]
PRESS RELEASE MAY 29, 2018 271 GREAT VALLEY PARKWAY MALVERN, PA 19355 LifeSensors Announces New Distribution Agreement with AmyJet in China LifeSensors Inc, a Biotech and Drug Discovery Company is pleased to announce our new partnership with Chinese distributor AmyJet Scientific. AmyJet Scientific Inc. was established in 2010 in Wuhan, Hubei Province, Tongi, Kowloon. As […]
Current Paradigms and Innovative Research Dear Colleagues, Alzheimer’s and Parkinson’s diseases are the silent killers. Despite a massive investment, the failure rate in drug development is 99.6%. The largest hurdle in developing a radical therapy for Alzheimer’s disease (AD) and Parkinson’s Disease (PD) is a lack of a simple diagnostic blood test. Current diagnostics are […]
Dear Colleagues, Deciphering the Ubiquitin Code is the first step in utilizing the Ubiquitin Proteasome System (UPS) to drug the so-called undruggable targets. LifeSensors is proud to present a new technology which will allow for much more precise and accurate targeting of the UPS. The new K48 TUBE HF was developed to show enhanced selectivity […]
